Carbidopa And Levodopa Capsule, Extended Release
NDC Package 70518-4621-0

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Carbidopa And Levodopa capsules is carbidopa and levodopa extended-release capsules are indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. This formulation utilizes a capsule, extended release delivery system. Marketed by Remedyrepack Inc., this product is identified by NDC 70518-4621 and is authorized under FDA application NDA203312.

Identification & Billing

NDC Package Code
70518-4621-0
Package Description
50 POUCH in 1 BOX / 1 CAPSULE, EXTENDED RELEASE in 1 POUCH (70518-4621-1)
Product Code
70518-4621
11-Digit Billing Format
70518462100
RxNorm Crosswalk
  • RxCUI: 1600914 - carbidopa 48.75 MG / levodopa 195 MG 8HR Extended Release Oral Capsule
  • RxCUI: 1600914 - 8 HR carbidopa 48.75 MG / levodopa 195 MG Extended Release Oral Capsule
  • RxCUI: 1600914 - 8 HR Carbidopa 48.75 MG / L-DOPA 195 MG Extended Release Oral Capsule
  • RxCUI: 1600914 - carbidopa 48.75 MG / levodopa 195 MG 8 HR Extended Release Oral Capsule

Clinical Specifications

Proprietary Name
Carbidopa And Levodopa
Non-Proprietary Name
Carbidopa And Levodopa
Substance Name
Carbidopa; Levodopa
Dosage Form
Capsule, Extended Release - A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Carbidopa and levodopa extended-release capsules are indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.

Regulatory & Marketing

Labeler Name
Remedyrepack Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA203312
Marketing Category
NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
Start Marketing Date
04-24-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70518-4621-0 identifies a specific commercial package of 50 pouch in 1 box / 1 capsule, extended release in 1 pouch (70518-4621-1) of Carbidopa And Levodopa, a human prescription drug labeled by Remedyrepack Inc.. This capsule, extended release is formulated for oral use and contains carbidopa; levodopa as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Remedyrepack Inc. on April 24, 2026. The current certification is valid through December 31, 2027.

How is this Remedyrepack Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70518462100. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70518-4621-0
11-Digit CMS (5-4-2)
70518-4621-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.